Unknown

Dataset Information

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.


ABSTRACT:

Introduction

Non-alcoholic fatty liver disease (NAFLD) results from increased hepatic total cholesterol (TC) and total triglyceride (TG) accumulation. In our previous study, we found that rats treated with hyperoside became resistant to hepatic lipid accumulation.

Objectives

The present study aims to investigate the possible mechanisms responsible for the inhibitory effects of hyperoside on the lipid accumulation in the liver tissues of the NAFLD rats.

Methods

Label-free proteomics and metabolomics targeting at bile acid (BA) metabolism were applied to disclose the mechanisms for hyperoside reducing hepatic lipid accumulation among the NAFLD rats.

Results

In response to hyperoside treatment, several proteins related to the fatty acid degradation pathway, choles

SUBMITTER: Wang S 

PROVIDER: S-EPMC8655136 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature